PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,300,987 | -13.5% | 56,577 | +3.0% | 0.52% | -20.2% |
| Q1 2023 | $2,659,647 | -19.6% | 54,906 | -36.7% | 0.64% | -14.8% |
| Q4 2022 | $3,309,034 | -24.0% | 86,692 | 0.0% | 0.76% | -32.5% |
| Q3 2022 | $4,352,000 | +28.0% | 86,692 | +2.2% | 1.12% | +47.4% |
| Q2 2022 | $3,400,000 | +14.1% | 84,864 | +6.3% | 0.76% | +17.4% |
| Q1 2022 | $2,980,000 | -35.0% | 79,864 | -11.7% | 0.65% | -31.6% |
| Q2 2020 | $4,587,000 | +35.3% | 90,396 | +18.9% | 0.95% | +31.0% |
| Q1 2020 | $3,390,000 | -29.6% | 75,996 | -24.2% | 0.72% | -6.2% |
| Q4 2019 | $4,813,000 | +17.2% | 100,202 | -17.5% | 0.77% | +11.1% |
| Q3 2019 | $4,106,000 | -60.2% | 121,402 | -47.1% | 0.69% | -58.2% |
| Q2 2019 | $10,327,000 | +40.9% | 229,498 | +17.8% | 1.66% | +41.2% |
| Q1 2019 | $7,330,000 | – | 194,743 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |